Skip to main content
SpringerLink
Log in

Anti-p200 Pemphigoid

  • Chapter
  • First Online:
Diseases of the Oral Mucosa

  • 1706 Accesses

Abstract

Anti-p200 pemphigoid is a rare subepidermal blistering disease first described in 1996. IgG and/or C3 can be detected by direct immunofluorescence microscopy (IF) at the basal membrane zone of the patient’s skin. Circulating antibodies bind to the blister floor of human salt-split skin in indirect IF and, characteristically, recognize a 200 kDa protein by immunoblotting with dermal extract. About 90% of anti-p200 pemphigoid patients have antibodies against laminin γ1 in addition. Clinically, the disease mimics bullous pemphigoid with tense blisters and erosions on the trunk and extremities as well as intense pruritus. In about 40% of patients, mucous membranes are also affected with oral (in 30% of patients), anogenital (in 10%), and conjunctival lesions (in 2%). Cutaneous lesions may heal with hyperpigmentations but without scarring. In some cases, milia are formed. Treatment is based on topical corticosteroids as well as oral prednisolone and immunomodulating drugs like dapsone and doxycycline.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, Liu Z, Giudice GJ, Tran HH, Marinkovich MP, Brocker EB, Hashimoto T. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol. 1996;106(6):1333–8.

    Article  CAS  Google Scholar 

  2. Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381(9863):320–32.

    Article  Google Scholar 

  3. Lau I, Goletz S, Holtsche MM, Zillikens D, Fechner K, Schmidt E. Anti-p200 pemphigoid is the most common pemphigoid disease with serum antibodies against the dermal side by indirect immunofluorescence microscopy on human salt-split skin. J Am Acad Dermatol. 2019;81(5):1195–7.

    Article  Google Scholar 

  4. van Beek N, Weidinger A, Schneider SW, Kleinheinz A, Gläser R, Holtsche MM, von Georg A, Hammers CM, Hübner F, Lima A-L, Gola D, Sadik CD, Zillikens D, Katalinic A, Schmidt E, König IR. Incidence of pemphigoid diseases in Northern Germany in 2016 – first data from the Schleswig‐Holstein Registry of Autoimmune Bullous Diseases. J Eur Acad Dermatol Venereol. 2021;35(5):1197–202.

    Google Scholar 

  5. Goletz S, Hashimoto T, Zillikens D, Schmidt E. Anti-p200 pemphigoid. J Am Acad Dermatol. 2014;71(1):185–91.

    Article  CAS  Google Scholar 

  6. Kridin K, Ahmed AR. Anti-p200 pemphigoid: a systematic review. Front Immunol. 2019;10:2466.

    Article  CAS  Google Scholar 

  7. Meijer JM, Diercks GF, Schmidt E, Pas HH, Jonkman MF. Laboratory diagnosis and clinical profile of anti-p200 pemphigoid. JAMA Dermatol. 2016;152(8):897–904.

    Article  Google Scholar 

  8. Mitsuya J, Hara H, Ito K, Ishii N, Hashimoto T, Terui T. Metastatic ovarian carcinoma-associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features. Br J Dermatol. 2008;158(6):1354–7.

    Article  CAS  Google Scholar 

  9. Goto-Ohguchi Y, Nishie W, Akiyama M, Tateishi Y, Aoyagi S, Tsuji-Abe Y, Sawamura D, Ishii N, Hashimoto T, Shimizu H. A severe and refractory case of anti-p200 pemphigoid resulting in multiple skin ulcers and scar formation. Dermatology. 2009;218(3):265–71.

    Article  CAS  Google Scholar 

  10. Iwata H, Hiramitsu Y, Aoyama Y, Kitajima Y. A case of anti-p200 pemphigoid: evidence for a different pathway in neutrophil recruitment compared with bullous pemphigoid. Br J Dermatol. 2009;160(2):462–4.

    Article  CAS  Google Scholar 

  11. Commin MH, Schmidt E, Duvert-Lehembre S, Lasek A, Morice C, Estival JL, Debarbieux S, Rigal E, Pauwels C, De Quatrebarbes J, Roussel A, Goujon E, Stoebner PE, Jouen F, Joly P. Clinical and immunological features and outcome of anti-p200 pemphigoid. Br J Dermatol. 2016;175(4):776–81.

    Article  CAS  Google Scholar 

  12. Dilling A, Rose C, Hashimoto T, Zillikens D, Shimanovich I. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease. J Dermatol. 2007;34(1):1–8.

    Article  Google Scholar 

  13. Mitate E, Kawano S, Nakao Y, Goto Y, Kobayashi I, Onozawa K, Hashimoto T, Nakamura S. Concurrence of autoantibodies to both laminin gamma1 and gamma2 subunits in a patient with kidney rejection response. Acta Derm Venereol. 2013;93(1):114–5.

    Article  Google Scholar 

  14. Holtsche MM, Goletz S, Zillikens D. Anti-p200 pemphigoid. Hautarzt. 2019;70(4):271–6.

    Article  CAS  Google Scholar 

  15. Schulze F, Kasperkiewicz M, Zillikens D, Schmidt E. Bullous pemphigoid. Hautarzt. 2013;64(12):931–43.

    Article  CAS  Google Scholar 

  16. Vodegel RM, Jonkman MF, Pas HH, de Jong MC. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol. 2004;151(1):112–8.

    Article  CAS  Google Scholar 

  17. Groth S, Recke A, Vafia K, Ludwig RJ, Hashimoto T, Zillikens D, Schmidt E. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid. Br J Dermatol. 2011;164(1):76–82.

    Article  CAS  Google Scholar 

  18. Dainichi T, Kurono S, Ohyama B, Ishii N, Sanzen N, Hayashi M, Shimono C, Taniguchi Y, Koga H, Karashima T, Yasumoto S, Zillikens D, Sekiguchi K, Hashimoto T. Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci U S A. 2009;106(8):2800–5.

    Article  CAS  Google Scholar 

  19. Groth S, Vafia K, Recke A, Dähnrich C, Zillikens D, Stöcker W, Kuhn A, Schmidt E. Antibodies to the C-terminus of laminin γ1 are present in a distinct subgroup of patients with systemic and cutaneous lupus erythematosus. Lupus. 2012;21(13):1482–3.

    Article  CAS  Google Scholar 

  20. Rose C, Weyers W, Denisjuk N, Hillen U, Zillikens D, Shimanovich I. Histopathology of anti-p200 pemphigoid. Am J Dermatopathol. 2007;29(2):119–24.

    Article  Google Scholar 

  21. Vafia K, Groth S, Beckmann T, Hirose M, Dworschak J, Recke A, Ludwig RJ, Hashimoto T, Zillikens D, Schmidt E. Pathogenicity of autoantibodies in anti-p200 pemphigoid. PLoS One. 2012;7(7):e41769.

    Article  CAS  Google Scholar 

  22. Koga H, Ishii N, Dainichi T, Tsuruta D, Hamada T, Ohata C, Karashima T, Furumura M, Hashimoto T. An attempt to develop mouse model for anti-laminin gamma1 pemphigoid. J Dermatol Sci. 2013;70(2):108–15.

    Article  CAS  Google Scholar 

  23. Holtsche MM, Goletz S, von Georg A, van Beek N, Hübner F, Pigors M, Zillikens D, Schmidt E. Serologic characterization of anti-p200 pemphigoid: epitope spreading as a common phenomenon. J Am Acad Dermatol. 2020; Epub ahead of print.

    Google Scholar 

  24. Schmidt ESM, Sárdy M, et al. S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update. J Dtsch Dermatol Ges. 2020;18(5):516–26.

    PubMed  Google Scholar 

  25. Schmidt E, Groves R. Immunobullous diseases. In: Griffith C, Barker J, Chalmers BT, Creamer D, editors. Rook’s textbook of dermatology, part 3, chapter 50. 9th ed. Chichester: Wiley-Blackwell; 2016. p. 1–56.

    Google Scholar 

  26. Raffin D, Delaplace M, Roussel A, Esteve E. Anti-p200 pemphigoid: remission under mycophenolate mofetil (Cellcept(R)). Ann Dermatol Venereol. 2013;140(12):784–7.

    Article  CAS  Google Scholar 

  27. Gawaz A, Metzler G, Hertl M, Hashimoto T, Schaller M. Treatment of anti-laminin gamma1 pemphigoid with mycophenolate mofetil. J Dtsch Dermatol Ges. 2015;13(7):696–7.

    PubMed  Google Scholar 

  28. Zhiliang L, Xiaodong Z, Peiying J, Suying F, Baoxi W. A case of refractory antilaminin gamma1 pemphigoid successfully treated with dexamethasone and mycophenolate mofetil. Int J Dermatol. 2015;54(5):e194–6.

    Article  Google Scholar 

  29. Pastar Z, Rados J, Lipozencic J, Dobric I, Marinovic B, Ishii N, Hashimoto T. Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid--how to treat it? Int J Dermatol. 2007;46(3):295–8.

    Article  CAS  Google Scholar 

  30. Rousseau L, Droitcourt C, Ropars N, Lelong B, Saillard C, Dupuy A. Successful treatment of severe anti-p200 pemphigoid in a heart transplant recipient with a single cycle of rituximab. JAAD Case Rep. 2017;3(3):175–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Lübeck, Lübeck, Germany

    Maike M. Holtsche & Detlef Zillikens

  2. Lübeck Institute of Experimental Dermatology (LIED) and Department of Dermatology, University of Lübeck, Lübeck, Germany

    Enno Schmidt

Authors
  1. Maike M. Holtsche
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Enno Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Detlef Zillikens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maike M. Holtsche .

Editor information

Editors and Affiliations

  1. Lübeck Institute of Experimental Dermatology (LIED) and Department of Dermatology, University of Lübeck, Lübeck, Germany

    Enno Schmidt

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Holtsche, M.M., Schmidt, E., Zillikens, D. (2021). Anti-p200 Pemphigoid. In: Schmidt, E. (eds) Diseases of the Oral Mucosa. Springer, Cham. https://doi.org/10.1007/978-3-030-82804-2_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-82804-2_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-82803-5

  • Online ISBN: 978-3-030-82804-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation